Bruno P. Coudert
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer Research top 1%
- Breast Cancer Treatment Studies
Papers in
- Oncology 68
- HER2/EGFR in Cancer Research 20
- Cancer Immunotherapy and Biomarkers 16
- Cancer Treatment and Pharmacology 12
- Lung Cancer Research Studies 8
-
- Breast Cancer Treatment Studies 25
- Co-authors
- P. Fumoleau (35 shared papers)Laurent Arnould (36 shared papers)Christian Focan (7 shared papers)Sylvie Giacchetti (6 shared papers)Francis Albert Lévi (7 shared papers)François Ghiringhelli (14 shared papers)Philippe J. M. Chollet (9 shared papers)Sylvain Ladoire (12 shared papers)
- Journals
- Annals of Oncology (16 papers)European Journal of Cancer (12 papers)Journal of Clinical Oncology (9 papers)British Journal of Cancer (7 papers)The Lancet Oncology (4 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Bruno P. Coudert
167 papers receiving 10.2k citations
Bruno P. Coudert's Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 5.6k
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 2.1k
- Endocrine and Autonomic Systems 427
- Radiology, Nuclear Medicine and Imaging 1.2k
Countries citing papers authored by Bruno P. Coudert
This map shows the geographic impact of Bruno P. Coudert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno P. Coudert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno P. Coudert more than expected).
Fields of papers citing papers by Bruno P. Coudert
This network shows the impact of papers produced by Bruno P. Coudert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno P. Coudert. The network helps show where Bruno P. Coudert may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno P. Coudert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer Hit paper breakdown → | 2000 | 1175 |
| 2 | Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Hit paper breakdown → | 2020 | 668 |
| 3 | Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Hit paper breakdown → | 2018 | 496 |
| 4 | Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer Hit paper breakdown → | 2021 | 477 |
| 5 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 6 | 2006 | 458 | |
| 7 | 2018 | 403 | |
| 8 | 2008 | 276 | |
| 9 | 2009 | 249 | |
| 10 | 2009 | 204 | |
| 11 | 2011 | 202 | |
| 12 | 2008 | 192 | |
| 13 | 2006 | 184 | |
| 14 | 2022 | 170 | |
| 15 | 2019 | 160 | |
| 16 | 2018 | 153 | |
| 17 | 2007 | 150 | |
| 18 | 2012 | 120 | |
| 19 | 2012 | 119 | |
| 20 | 2003 | 117 |
About Bruno P. Coudert
Bruno P. Coudert is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems and Radiology, Nuclear Medicine and Imaging, having authored 172 papers that have together received 10.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Breast Cancer Treatment Studies (25 papers), HER2/EGFR in Cancer Research (20 papers), Cancer Immunotherapy and Biomarkers (16 papers), Cancer Treatment and Pharmacology (12 papers), Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Research Studies (8 papers) and Chemotherapy-induced cardiotoxicity and mitigation (6 papers). The work is most often cited by research in Oncology (5.6k citations), Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (2.1k citations), Endocrine and Autonomic Systems (427 citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Bruno P. Coudert has collaborated with scholars based in France, United States and Italy. Frequent co-authors include P. Fumoleau, Laurent Arnould, Christian Focan, Sylvie Giacchetti, Francis Albert Lévi, François Ghiringhelli, Philippe J. M. Chollet, Sylvain Ladoire, Roberto Faggiuolo and R. Adam. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, British Journal of Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.